Organovo Announces Fiscal Second-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook
03 nov. 2016 16h05 HE
|
Organovo, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
01 nov. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Nov. 01, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results
24 oct. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using...
Organovo Prices Approximately $25 Million Public Offering of Common Stock
20 oct. 2016 09h11 HE
|
Organovo, Inc.
SAN DIEGO, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Proposed Public Offering of Common Stock
19 oct. 2016 16h07 HE
|
Organovo, Inc.
SAN DIEGO, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Select Preliminary Second-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Outlook
11 oct. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
05 oct. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to Fibrosis
13 sept. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Announces Initiation of Commercial Contracting for ExVive Human Kidney Tissue
07 sept. 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...
Organovo Appoints Two New Members to Board of Directors
18 août 2016 08h05 HE
|
Organovo, Inc.
SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs...